IDBS is a unique provider of data management, analytics and modelling solutions to R&D and healthcare organisations. Our software powers some of the world's leading scientific organisations including Pfizer, BASF, L'Oréal, Roche, Amgen, Bayer, Genentech, Astellas and Daiichi-Sankyo, enabling them to transform their R&D through better use of their data.
IDBS receives the Queen's Award for growth in overseas revenues over the last three years, by £8m to a cumulative total of £51m. Head-quartered in Guildford, Surrey, IDBS has worldwide operations across the United States, Europe and throughout Asia Pacific. The company has expanded rapidly in these overseas markets, and continues to open direct sales and support centres worldwide.
Neil Kipling, founder and CEO of IDBS said: "As the only British company in our sector, competing exclusively against overseas players, we are absolutely delighted to receive this prestigious award. Our growth has been achieved through the development and commercialisation of innovative new products, accessing new and growing markets and an absolute commitment to the highest standards by our employees around the world. I am thrilled to see our recent impact recognised in this manner."
 

Improving R&D Efficiency
IDBS works with more than 200 of the world's leading pharmaceutical, medical and industrial research organisations, helping them realise the full potential of their data. 
The company produces the fastest growing data management product for R&D scientists - E-WorkBook - which has demonstrated 30-60% improvements in R&D efficiency by providing improved collaboration, decision-making and data security. Each improvement speeds time-to-market and reduces overall costs.
IDBS is transforming the way in which the world's leading organ
isations research and develop therapeutics. The same approach 
is also applied to energy, consumer goods, engineering and the chemicals industry, enabling researchers to gain previously impossible insights into their data.
 

Enabling Personalised Medicine
Delivering the right treatment to the right patient at the right time 
is key to changing healthcare, with improved, more cost-effective outcomes for patients. IDBS has been working with pioneering Academic Health Science Centres within the NHS to advance the delivery of personalised medicine. By better understanding the relationships between genes and disease at the point of care, doctors can treat patients in a more directed, personal way and share the success of their treatments with colleagues, further improving clinical practice.
"IDBS is a company with passion and a genuine cause, to 'Power Science for a Better Future,' "says Neil Kipling. "It's part of everything we do and absolutely linked to customer success. We remain at the forefront of our industry by looking to the future and investing in the product developments we believe will transform their businesses."

IDBS
2 Occam Court
Surrey Research Park
Guildford 
GU2 7QB  UK
Tel: +44 (0) 1483 595 000
Fax: +44 (0) 1483 595 001
info@idbs.com
www.idbs.com
www.twitter.com/@IDBSsoftware